Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer

Radiotherapy and Oncology

Volumn 53, Issue 3, 1999, Pages 219-226

  Bentzen, Søren M ^a   Saunders, Michele I ^a   Dische, Stanley ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

CHART; Monte Carlo sampling; Repair halftimes

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD CANCER; HUMAN; LARYNX EDEMA; MAJOR CLINICAL STUDY; MORBIDITY; NECK CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; SKIN FIBROSIS; TELANGIECTASIA;

CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROSIS; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LARYNGEAL EDEMA; MONTE CARLO METHOD; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SKIN; SKIN DISEASES, VASCULAR; TELANGIECTASIS; TIME FACTORS; WOUND HEALING;

EID: 0032761213     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00151-6     Document Type: Article

References (24)

1. Ang K.K., Jiang G.L., Guttenberger R., et al. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiother. Oncol. 25:1992;287-294.
2. Baumann M., Bentzen S.M., Ang K.K. Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data. Radiother. Oncol. 46:1998;127-130.
3. Beck-Bornholdt H.P., Dubben H.H., Liertz-Petersen C., Willers H. Hyperfractionation: where do we stand? Radiother. Oncol. 43:1997;1-21.
4. Bentzen S.M. Radiobiological considerations in the design of clinical trials. Radiother. Oncol. 32:1994;1-11.
5. Bentzen S.M. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother. Oncol. 46:1998;5-18.
6. Bentzen S.M., Overgaard J. Clinical normal-tissue radiobiology. Tobias J.S., Thomas P.R.M. Current radiation oncology. 1996;37-67 Arnold, London.
7. Bentzen S.M., Overgaard M. Early and late normal-tissue injury after postmastectomy radiotherapy. Hinkelbein W., Bruggmoser G., Frommhold H., Wannenmacher M. Acute and long-term side-effects of radiotherapy. 1993;59-78 Springer-Verlag, Berlin.
8. Bentzen S.M., Ruifrok A.C.C., Thames H.D. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother. Oncol. 38:1996;89-101.
9. Bentzen S.M., Thames H.D., Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother. Oncol. 15:1989;267-274.
10. Bentzen S.M., Tucker S.L. Quantifying the position and steepness of dose-response curves. Int. J. Radiat. Biol. 71:1997;531-542.
11. Bentzen S.M., Turesson I., Thames H.D. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy. A graded response analysis. Radiother. Oncol. 18:1990;95-106.
12. Dische S. Accelerated treatment and radiation myelitis. Radiother. Oncol. 20:1991;1-2.
13. Dische S., Saunders M.I., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44:1997;123-136.
14. Guttenberger R., Thames H.D., Ang K.K. Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations. Radiother. Oncol. 25:1992;280-286.
15. Horiot J.C., Bontemps P., Van den Bogaert W., et al. Accelerated fractionation (AF) compared with conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomised trial. Radiother. Oncol. 44:1997;111-121.
16. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomised trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25:1992;231-241.
17. Millar W.T., Jen Y.M., Hendry J.H., Canney P.A. Two components of repair in irradiated kidney colony forming cells. Int. J. Radiat. Biol. 66:1994;189-196.
18. Millar W.T., Van Den Aardweg G.J., Hopewell J.W., Canney P.A. Repair kinetics in pig epidermis: an analysis based on two separate rates of repair. Int. J Radiat. Biol. 69:1996;123-140.
19. Nyman J., Turesson I. Does the interval between fractions matter in the range 4-8 h in radiotherapy? A study of acute and late human skin reactions. Radiother. Oncol. 34:1995;171-178.
20. Overgaard J., Hjelm-Hansen M., Johansen L.V., Andersen A.P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27:1988;147-152.
21. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient II. Analysis and examples. Br. J. Cancer. 35:1977;1-39.
22. Thames H.D. An 'incomplete-repair' model for survival after fractionated and continuous irradiations. Int. J. Radiat. Biol. 47:1985;319-339.
23. Turesson I., Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction. I. Comparison of the effects of daily and once-a-week fractionation on human skin. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;593-598.
24. Turesson I., Thames H.D. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother. Oncol. 15:1989;169-188.